Exploratory study of onset predictor and drug resistor factors of central nerve system metastasis by omics methods, using cerebrospinal fluid.
Not Applicable
Recruiting
- Conditions
- ung cancer
- Registration Number
- JPRN-UMIN000030756
- Lead Sponsor
- Gunma University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1) Case in which lumbar puncture and cerebrospinal fluid sampling can not be performed due to some reason (insufficient examination position, danger of cerebral hernia due to puncture, etc.)). 2) Cases judged by the attending doctor that there is a problem with the ability to consent or to understand the study plan. 3) Cases with unstable mental disorders. 4) Other cases that the attending doctor judged inappropriate, in this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection of biomarkers involved in affinity of tumor cells to the central nervous system.
- Secondary Outcome Measures
Name Time Method Detection of factors involved in resistant to the anti-cancer agents of central nervous system metastasis.